Roles of mTOR in Diabetic Kidney Disease
Diabetic kidney disease (DKD) is the leading cause of end-stage renal disease and the number of patients affected is increasing worldwide. Thus, there is a need to establish a new treatment for DKD to improve the renal prognosis of diabetic patients. Recently, it has shown that intracellular metabol...
Main Authors: | Mako Yasuda-Yamahara, Shinji Kume, Hiroshi Maegawa |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-02-01
|
Series: | Antioxidants |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3921/10/2/321 |
Similar Items
-
Dysregulation of mTOR Signaling after Brain Ischemia
by: Mario Villa-González, et al.
Published: (2022-03-01) -
mTOR Cross-Talk in Cancer and Potential for Combination Therapy
by: Fabiana Conciatori, et al.
Published: (2018-01-01) -
The Bumpy Road towards mTOR Inhibition in Glioblastoma: Quo Vadis?
by: Kostas A. Papavassiliou, et al.
Published: (2021-12-01) -
Not only a therapeutic target; mTOR in Hodgkin lymphoma and acute lymphoblastic leukemia
by: Miguel Enrique Cuéllar Mendoza, et al.
Published: (2024-02-01) -
4.4 Å Resolution Cryo-EM structure of human mTOR Complex 1
by: Huirong Yang, et al.
Published: (2016-12-01)